Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 5/20 | 0.37 |
| ▸ | DRD2 | P14416 | 4/20 | 0.37 |
| ▸ | HTR1A | P08908 | 2/20 | 0.37 |
| ▸ | HTR2A | P28223 | 2/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 2/20 | 0.36 |
| ▸ | DRD1 | P21728 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4163722 | 0.84 | CA1 (0.36) | — | |
| SCHEMBL4597673 | 0.83 | SLC6A2 (0.39) | DRD2HTR1AHTR2ASLC6A2SLC6A4 | |
| SCHEMBL4595444 | 0.82 | SIGMAR1 (0.46) | HTR2AMAOB | |
| SCHEMBL4597107 | 0.82 | DRD2 (0.46) | DRD2HTR1AHTR2A | |
| SCHEMBL4172727 | 0.80 | CA1 (0.34) | — | |
| SCHEMBL4596757 | 0.77 | HTT (0.41) | — | |
| SCHEMBL4596810 | 0.77 | KCNH2 (0.46) | HTR2ASLC6A2SLC6A4 | |
| SCHEMBL9298888 | 0.76 | CA1 (0.34) | — | |
| SCHEMBL4597148 | 0.75 | LDHA (0.43) | DRD2DRD3 | |
| SCHEMBL4595660 | 0.75 | KDM4E (0.42) | DRD2SLC6A2SLC6A4SLC6A3DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1874788-A1 | MONOSACCHARIDE DERIVATIVES AS ANTI-INFLAMMATORY AND/OR ANTI-CANCER AGENTS | Ranbaxy Laboratories Limited (IN) | 2008-01-09 | — | — | EP | disclosed |
| WO-2006111783-A1 | MONOSACCHARIDE DERIVATIVES AS ANTI-INFLAMMATORY AND/OR ANTI-CANCER AGENTS | RANBAXY LABORATORIES LIMITED (IN) | 2006-10-26 | — | — | WO | disclosed |